MCID: ATN002
MIFTS: 48

Autonomic Nervous System Disease malady

Categories: Neuronal diseases

Aliases & Classifications for Autonomic Nervous System Disease

Aliases & Descriptions for Autonomic Nervous System Disease:

Name: Autonomic Nervous System Disease 12 14
Autonomic Nervous System Disorders 41 69
Autonomic Nervous System Disorder 12 29

Classifications:



External Ids:

Disease Ontology 12 DOID:11465
ICD9CM 35 337.1
ICD10 33 G90 G90.8 G99.1
UMLS 69 C0154691

Summaries for Autonomic Nervous System Disease

MedlinePlus : 41 your autonomic nervous system is the part of your nervous system that controls involuntary actions, such as the beating of your heart and the widening or narrowing of your blood vessels. when something goes wrong in this system, it can cause serious problems, including blood pressure problems heart problems trouble with breathing and swallowing erectile dysfunction in men autonomic nervous system disorders can occur alone or as the result of another disease, such as parkinson's disease, alcoholism and diabetes. problems can affect either part of the system, as in complex regional pain syndromes, or all of the system. some types are temporary, but many worsen over time. when they affect your breathing or heart function, these disorders can be life-threatening. some autonomic nervous system disorders get better when an underlying disease is treated. often, however, there is no cure. in that case, the goal of treatment is to improve symptoms. nih: national institute of neurological disorders and stroke

MalaCards based summary : Autonomic Nervous System Disease, also known as autonomic nervous system disorders, is related to autonomic dysfunction and autonomic peripheral neuropathy, and has symptoms including back pain, constipation and diarrhea. An important gene associated with Autonomic Nervous System Disease is INS (Insulin), and among its related pathways/superpathways are Neuroscience and Embryonic and Induced Pluripotent Stem Cell Differentiation Pathways and Lineage-specific Markers. The drugs Benzocaine and Dopamine have been mentioned in the context of this disorder. Affiliated tissues include heart and skin, and related phenotypes are behavior/neurological and normal

Related Diseases for Autonomic Nervous System Disease

Diseases related to Autonomic Nervous System Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 68)
id Related Disease Score Top Affiliating Genes
1 autonomic dysfunction 11.1
2 autonomic peripheral neuropathy 11.1
3 central hypoventilation syndrome, congenital 10.9
4 phaeochromocytoma 10.3 ALB TTR
5 febrile seizures, familial, 10 10.3 NPS TAC1
6 ehlers-danlos syndrome, periodontal type 1 10.3 ALB TTR
7 leber congenital amaurosis 12 10.3 NPS TAC1
8 malignant renovascular hypertension 10.3 NGF TAC1
9 cartilage disease 10.3 CALCA TAC1
10 paranasal sinus cancer, adult 10.3 CALCA INS
11 pseudoinflammatory fundus dystrophy 10.2 NGF TAC1
12 malignant visceral pleura tumor 10.2 CALCA NGF
13 breast fibroadenoma 10.2 HBA2 INS
14 brain ependymoma 10.2 CALCA INS
15 cataract 10.2 ALB INS TTR
16 placenta accreta 10.2 CALCA NPS TAC1
17 vulvar dystrophy 10.2 HBA1 INS
18 shaken baby syndrome 10.2 DBH INS
19 boutonneuse fever 10.2 NPS TAC1
20 submucous uterine fibroid 10.2 ALB HBA2 INS
21 hypersensitivity syndrome, carbamazepine-induced 10.2 ALB HBA2 INS
22 hypersensitivity pneumonitis, familial 10.2 HBA1 HBA2
23 chronic myocardial ischemia 10.2 ALB INS TTR
24 ichthyosis, congenital, autosomal recessive 8 10.2 HBA1 HBA2
25 michelin tire baby syndrome 10.2 HBA1 HBA2
26 aortic valve prolapse 10.2 ALB NGF TTR
27 vascular disease 10.2 ALB EDNRB
28 hydrocephalus due to congenital stenosis of aqueduct of sylvius 10.2 HBA1 HBA2
29 immunodeficiency by defective expression of hla class 1 10.2 CALCA EDNRB
30 surfactant metabolism dysfunction, pulmonary, 3 10.2 HBA1 HBA2
31 male genital organ stricture 10.2 ALB TTR
32 superior vena cava angiosarcoma 10.2 CALCA HBA1
33 cockayne syndrome type i 10.2 CALCA INS NPY
34 rumination disorder 10.1 DBH INS NGF
35 familial spastic paralysis 10.1 DBH NGF
36 central nervous system lymphoma 10.1 CALCA NPY TAC1
37 infantile hypotonia 10.1 CALCA NPY TAC1
38 inner ear disease 10.1 ALB TTR
39 alzheimer's disease 11 10.1 HBA1 HBA2
40 paroxysmal nonkinesigenic dyskinesia 2 10.1 HBA1 HBA2 INS
41 pleuropulmonary blastoma 10.1 HBA1 HBA2 INS
42 ovarian endometrioid cystadenoma 10.1 CALCA HBA1 NPS
43 dyspepsia 10.1 NPY TAC1
44 lung occult small cell carcinoma 10.1 CALCA NGF
45 uterine ligament clear cell adenocarcinoma 10.1 ALB EDNRB TAC1
46 lmna-related cardiocutaneous progeria syndrome 10.1 HBA1 HBA2
47 cerebellar hypoplasia with endosteal sclerosis 10.0 CALCA CHSY1 NPS NPY
48 female infertility of uterine origin 10.0 ALB TTR
49 fissured tongue 10.0 ALB INS NGF NPY
50 vernal conjunctivitis 10.0 ALB HBA1 HBA2 INS

Comorbidity relations with Autonomic Nervous System Disease via Phenotypic Disease Network (PDN):


Acute Cystitis Deficiency Anemia
Hypertension, Essential Hypothyroidism
Ischemic Heart Disease Parkinson Disease, Late-Onset
Peripheral Vascular Disease

Graphical network of the top 20 diseases related to Autonomic Nervous System Disease:



Diseases related to Autonomic Nervous System Disease

Symptoms & Phenotypes for Autonomic Nervous System Disease

UMLS symptoms related to Autonomic Nervous System Disease:


back pain, constipation, diarrhea, headache, mydriasis, pain, rectal pain, sciatica, seizures, syncope, tremor, vomiting, chronic pain, lightheadedness, rectal tenesmus, warm skin, dry throat, palpitations - fluttering, pounding heart, syncope, effort, hyperemesis, anal pain, vomiting in newborn, blackout - symptom, vertigo/dizziness, increased sweating, vomiting alone, sleeplessness

MGI Mouse Phenotypes related to Autonomic Nervous System Disease:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 9.81 ASCL1 CHSY1 DBH EDNRB INS NGF
2 normal MP:0002873 9.56 ALB ASCL1 DBH INS NGF NPY
3 vision/eye MP:0005391 9.23 ASCL1 CHSY1 DBH EDNRB INS NGF

Drugs & Therapeutics for Autonomic Nervous System Disease

Drugs for Autonomic Nervous System Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 1370)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Benzocaine Approved Phase 4,Phase 3,Phase 2,Phase 1 1994-09-7, 94-09-7 2337
2
Dopamine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 51-61-6, 62-31-7 681
3
Risperidone Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 106266-06-2 5073
4
Zolpidem Approved Phase 4,Phase 3,Phase 1 82626-48-0 5732
5 Zotepine Approved Phase 4 26615-21-4
6
Acetylcholine Approved Phase 4,Phase 2,Phase 3,Phase 1 51-84-3 187
7
Lidocaine Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 137-58-6 3676
8
Citalopram Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 59729-33-8 2771
9
Ursodeoxycholic acid Approved, Investigational Phase 4,Phase 3 128-13-2 31401
10
Galantamine Approved Phase 4,Phase 3,Phase 2,Phase 1 357-70-0 9651 908828, 9651
11
Nicotine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 54-11-5 942 89594
12 Beractant Approved Phase 4 108778-82-1
13
Budesonide Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 51333-22-3 63006 5281004
14
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 83-43-2 6741
15
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 50-24-8 5755
16
Fluoxetine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 54910-89-3 3386
17
Fluvoxamine Approved, Investigational Phase 4,Phase 3 54739-18-3 3404 5324346
18
Paroxetine Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 61869-08-7 43815
19
Sertraline Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 79617-96-2 68617
20
Carbidopa Approved Phase 4,Phase 3,Phase 2,Phase 1 28860-95-9 34359 38101
21
Levodopa Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 59-92-7 6047
22
Diazepam Approved, Illicit, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 439-14-5 3016
23
Bupropion Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 34841-39-9, 34911-55-2 444
24
Histamine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 75614-87-8, 51-45-6 774
25
Mianserin Approved Phase 4,Phase 3,Phase 2,Early Phase 1 24219-97-4 4184
26
Mirtazapine Approved Phase 4,Phase 3,Phase 2,Early Phase 1 85650-52-8, 61337-67-5 4205
27
Norepinephrine Approved Phase 4,Phase 2,Phase 3,Phase 1 51-41-2 439260
28
Trazodone Approved, Investigational Phase 4,Phase 3 19794-93-5 5533
29
Terbutaline Approved Phase 4,Phase 3,Phase 2,Phase 1 23031-25-6 5403
30
Metoprolol Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 37350-58-6, 51384-51-1 4171
31
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-78-2 2244
32
Cilostazol Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 73963-72-1 2754
33
Everolimus Approved Phase 4,Phase 1,Phase 2 159351-69-6 6442177
34
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
35
Sirolimus Approved, Investigational Phase 4,Phase 1,Phase 2 53123-88-9 5284616 6436030 46835353
36
Ticlopidine Approved Phase 4 55142-85-3 5472
37
Carbamazepine Approved, Investigational Phase 4,Phase 3,Phase 2 298-46-4 2554
38
Coal tar Approved Phase 4,Phase 2 8007-45-2
39
Olanzapine Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 132539-06-1 4585
40
Oxcarbazepine Approved Phase 4,Phase 3 28721-07-5 34312
41
Valproic Acid Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 99-66-1 3121
42
Ziprasidone Approved Phase 4,Phase 3,Phase 2,Phase 1 146939-27-7 60854
43
Clonidine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 4205-90-7 2803
44
Domperidone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 57808-66-9 3151
45
Omeprazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 73590-58-6 4594
46
Reboxetine Approved, Investigational Phase 4,Phase 3 98769-81-4, 71620-89-8 123628 65856
47
Nitric Oxide Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 10102-43-9 145068
48
Atenolol Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 29122-68-7 2249
49
Nicorandil Approved Phase 4 65141-46-0 47528
50
Mannitol Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 69-65-8 453 6251

Interventional clinical trials:

(show top 50) (show all 5000)
id Name Status NCT ID Phase
1 Effect of Rotigotine Patch Treatment on Cardiovascular Markers in Idiopathic Restless Legs Syndrome Unknown status NCT01823770 Phase 4
2 Risperidone and Zotepine in the Treatment of Delirium Unknown status NCT00622011 Phase 4
3 Botox for Neurogenic Detrusor Overactivity and the Prevention of Autonomic Dysreflexia Following SCI Unknown status NCT02298660 Phase 4
4 Botulinum A Toxin in Patients With Parkinson's Disease Unknown status NCT00822913 Phase 4
5 The Effects of Continuous Positive Airway Pressure on Overlap Syndrome Unknown status NCT00914264 Phase 4
6 Closed Loop Stimulation for Neuromediated Syncope (SPAIN Study) Unknown status NCT01621464 Phase 4
7 Cardiovascular Effects of Agomelatine and Escitalopram in Patients With Major Depressive Disorder (MDD) Unknown status NCT01483053 Phase 4
8 Inspiratory Muscle Training in Patients With Autonomic Neuropathic Unknown status NCT00752440 Phase 4
9 Bi-Axial Rotating Magnetic Field Therapy in Refractory Neuropathic Foot Pain Secondary to Diabetic Peripheral Neuropathy Unknown status NCT00123136 Phase 4
10 Efficacy and Safety of Ursodeoxycholic Acid (UDCA) Added to the DPP-4 Inhibitor in People With Type 2 Diabetes and Chronic Liver Diseases Unknown status NCT01337440 Phase 4
11 Chronic Treatment With Benfotiamine Restores Endothelial Function in People With Type 2 Diabetes Mellitus Unknown status NCT00446810 Phase 4
12 Study on Magnetic Field Therapy to Improve Quality of Sleep and Reduction of Chronic Spine Pain Unknown status NCT00445133 Phase 4
13 The Impact of the French PNNS Guidelines on Vascular Function Following a Standardised Breakfast. Unknown status NCT01579409 Phase 4
14 Study on Magnetic Field Therapy to Improve Chronic Lumbar Pain Unknown status NCT00444990 Phase 4
15 Neurophysiologic Changes in Patients With Bipolar Depression Unknown status NCT01213121 Phase 4
16 Diffusion Tensor Weighted MRI in Alzheimer's Disease Modifying Treatment Effects of Galantamine (Reminyl®) Unknown status NCT00523666 Phase 4
17 Nicotine Treatment of Impulsivity in Parkinson's Disease Unknown status NCT01216904 Phase 4
18 Prevention of Chronic Lung Disease (CLD) in Preterm Infants Unknown status NCT00883532 Phase 4
19 Adverse Effects of Glucocorticoid Therapy on Bone in Childhood Crohn's Disease Unknown status NCT00609752 Phase 4
20 The Efficacy of Methylprednisolone in the Treatment of Patients With Ocular Involvement in Behcet's Disease Unknown status NCT01306955 Phase 4
21 Magnetic Resonance Imaging Study of Cognitive-Behavior Therapy for Major Depressive Disorder Unknown status NCT01460212 Phase 4
22 Comparing Treatment Efficacy With HD/MD Flu Plus Sal in Chronic Obstructive Pulmonary Disease (COPD) Patients Unknown status NCT01131806 Phase 4
23 Remission of ICD by Switching Dopamine Agonist to Levodopa/Carbidopa Unknown status NCT01683253 Phase 4
24 Compare the Effects of Fluticasone Furoate Nasal Spray vs Placebo in Patients With Nasal Polypoid Disease Unknown status NCT01013701 Phase 4
25 Prevention of Posttraumatic Stress Disorder (PTSD) With Diazepam Unknown status NCT01221883 Phase 4
26 Algorithm Guided Treatment Strategies for Major Depressive Disorder Unknown status NCT01764867 Phase 4
27 Efficacy and Safety of Tulobuterol Patch Combined With Tiotropium Bromide for Relieving Dyspnea Symptom of Chronic Obstructive Pulmonary Disease Unknown status NCT01465906 Phase 4
28 Can Advair and Flovent Reduce Systemic Inflammation Related to Chronic Obstructive Pulmonary Disease (COPD)? A Multi-Center Randomized Controlled Trial Unknown status NCT00120978 Phase 4
29 The Relationship Between Risperdal Treatment and Quality of Life in Patients With Alzheimer's Disease and Behavioural and Psychological Symptoms of Dementia (BPSD) Unknown status NCT00626613 Phase 4
30 Metoprolol and Formoterol in Chronic Obstructive Pulmonary Disease (COPD) Unknown status NCT00288548 Phase 4
31 Treatment Youth With Obsessive-Compulsive Disorder Unknown status NCT00708240 Phase 4
32 Medications for the Treatment of Dysthymic Disorder and Double Depression Unknown status NCT00234312 Phase 4
33 Comparing Treatments for Self-Injury and Suicidal Behavior in People With Borderline Personality Disorder Unknown status NCT00834834 Phase 4
34 Study of Escitalopram Versus Placebo in the Treatment of Depressive Syndrome in Alzheimer’s Disease, Vascular Dementia, and Mixed Vascular and Alzheimer’s Dementia Unknown status NCT00229333 Phase 4
35 Role of Dopamine on Loss Aversion Behaviour: Study on Parkinsonian Patients Unknown status NCT01780467 Phase 4
36 Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - SAfety & EffectiveneSS of Drug-ElUting Stents & Anti-platelet REgimen Unknown status NCT01267734 Phase 4
37 Extra-fine Formoterol/Beclomethasone in Asthmatic Crisis Unknown status NCT02345993 Phase 4
38 Escitalopram and Sleep Architecture in Patients With Major Depressive Disorder Unknown status NCT00442481 Phase 4
39 Comparative Efficacy and Acceptability of Antimanic Drugs in Acute Mania Unknown status NCT01893229 Phase 4
40 Study of Clonidine on Sleep Architecture in Children With Tourette's Syndrome (TS) and Comorbid ADHD Unknown status NCT00152750 Phase 4
41 Research of Efficient Use of Omeprazole in Combination With Domperidone in Gastroesophageal Reflux Disease of Mild to Moderate Severity Unknown status NCT02140073 Phase 4
42 Effect of Escitalopram vs. Reboxetine on Gastro-intestinal Sensitivity of Patients With Major Depressive Disorder Unknown status NCT00209807 Phase 4
43 Assessment of Utility of Exhaled Nitric Oxide Measurement for Treatment Monitoring in Children With Asthma Unknown status NCT00500253 Phase 4
44 Study to Assess Efficacy of Nicorandil+Atenolol vs Atenolol in Treatment of Chronic Stable Angina. Unknown status NCT01397994 Phase 4
45 Predictor for an Additional Benefit of Inhaled Corticosteroid in Patients Treated With Tiotropium for COPD Unknown status NCT00860938 Phase 4
46 The Efficacy and Safety of Salmeterol/Fluticasone Propionate vs Atropium/Albuterol in Patients COPD Unknown status NCT01243788 Phase 4
47 The Effect of IV Amantadine on Freezing of Gait (FOG) Resistant to Dopaminergic Therapy Unknown status NCT01313819 Phase 4
48 Comparison of Efficacy of Ivabradine Versus Metoprolol Unknown status NCT01755663 Phase 4
49 German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003) Unknown status NCT00198991 Phase 4
50 TNF-blocking Therapy in Combination With Disease-modifying Antirheumatic Drugs in Early Rheumatoid Arthritis Unknown status NCT00908089 Phase 4

Search NIH Clinical Center for Autonomic Nervous System Disease

Genetic Tests for Autonomic Nervous System Disease

Genetic tests related to Autonomic Nervous System Disease:

id Genetic test Affiliating Genes
1 Abnormality of the Autonomic Nervous System 29

Anatomical Context for Autonomic Nervous System Disease

MalaCards organs/tissues related to Autonomic Nervous System Disease:

39
Heart, Skin

Publications for Autonomic Nervous System Disease

Variations for Autonomic Nervous System Disease

ClinVar genetic disease variations for Autonomic Nervous System Disease:

6
id Gene Variation Type Significance SNP ID Assembly Location
1 DRD4 NM_000797.3(DRD4): c.235_247delGCCGACCTCCTCC (p.Ala79Serfs) deletion Pathogenic rs587776842 GRCh38 Chromosome 11, 637539: 637551

Expression for Autonomic Nervous System Disease

Search GEO for disease gene expression data for Autonomic Nervous System Disease.

Pathways for Autonomic Nervous System Disease

GO Terms for Autonomic Nervous System Disease

Cellular components related to Autonomic Nervous System Disease according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.61 ALB CALCA DBH HBA1 HBA2 INS
2 extracellular region GO:0005576 9.4 ALB CALCA CHSY1 DBH HBA1 HBA2
3 endocytic vesicle lumen GO:0071682 9.32 HBA1 HBA2
4 hemoglobin complex GO:0005833 9.26 HBA1 HBA2
5 haptoglobin-hemoglobin complex GO:0031838 9.16 HBA1 HBA2

Biological processes related to Autonomic Nervous System Disease according to GeneCards Suite gene sharing:

(show all 22)
id Name GO ID Score Top Affiliating Genes
1 cell-cell signaling GO:0007267 9.81 CALCA INS NGF TAC1
2 positive regulation of cytosolic calcium ion concentration GO:0007204 9.77 CALCA EDNRB TAC1
3 cellular protein metabolic process GO:0044267 9.67 ALB CALCA INS TTR
4 positive regulation of vasodilation GO:0045909 9.61 CALCA INS
5 vasodilation GO:0042311 9.6 CALCA EDNRB
6 negative regulation of ossification GO:0030279 9.58 CALCA CHSY1
7 hydrogen peroxide catabolic process GO:0042744 9.58 HBA1 HBA2
8 cellular oxidant detoxification GO:0098869 9.58 ALB HBA1 HBA2
9 glial cell differentiation GO:0010001 9.57 ASCL1 PHOX2B
10 sympathetic nervous system development GO:0048485 9.56 ASCL1 PHOX2B
11 positive regulation of ossification GO:0045778 9.55 CALCA TAC1
12 oxygen transport GO:0015671 9.54 HBA1 HBA2
13 central nervous system neuron development GO:0021954 9.52 ASCL1 NPY
14 positive regulation of renal sodium excretion GO:0035815 9.49 EDNRB TAC1
15 positive regulation of synaptic transmission, GABAergic GO:0032230 9.48 NPS TAC1
16 enteric nervous system development GO:0048484 9.46 EDNRB PHOX2B
17 neuropeptide signaling pathway GO:0007218 9.46 CALCA NPS NPY TAC1
18 sympathetic ganglion development GO:0061549 9.43 ASCL1 PHOX2B
19 positive regulation of action potential GO:0045760 9.32 NPS TAC1
20 noradrenergic neuron development GO:0003358 9.26 ASCL1 PHOX2B
21 regulation of blood pressure GO:0008217 9.26 CALCA EDNRB NPY TAC1
22 response to pain GO:0048265 8.92 CALCA DBH EDNRB TAC1

Molecular functions related to Autonomic Nervous System Disease according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 oxygen binding GO:0019825 9.33 ALB HBA1 HBA2
2 oxygen transporter activity GO:0005344 9.26 HBA1 HBA2
3 haptoglobin binding GO:0031720 8.96 HBA1 HBA2
4 hormone activity GO:0005179 8.92 CALCA INS NPY TTR

Sources for Autonomic Nervous System Disease

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....